Report of a workshop: disease accentuation after immunization with inactivated microbial vaccines.
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000914:Antibodies, Viral / Q000032:analysis; D000917:Antibody Formation; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines / Q000009:adverse effects*; D002689:Chlamydia / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D008457:Measles / Q000276:immunology; D008458:Measles Vaccine / Q000009:adverse effects; D008459:Measles virus / Q000276:immunology; D009174:Mycoplasma / Q000276:immunology; D009175:Mycoplasma Infections / Q000276:immunology; D011323:Primates; D012136:Respiratory Syncytial Viruses / Q000276:immunology; D012141:Respiratory Tract Infections / Q000276:immunology; D014141:Trachoma / Q000276:immunology; D014611:Vaccination / Q000009:adverse effects*; D014765:Viral Vaccines / Q000009:adverse effects*
D000907:Antibodies, Bacterial; D000914:Antibodies, Viral; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D008458:Measles Vaccine; D014765:Viral Vaccines